Uptake and Acceptability of Home-use of Mifepristone for Medical Abortion

Completed · Not applicable

Conditions studied: Termination of Pregnancy

In brief

The primary aim of this study is to assess the acceptability of home-use mifepristone for termination of pregnancy among women who choose it and their providers. The investigators' secondary aims are to assess rates of follow-up, adherence, efficacy, complications, lost productivity, and to estimate the minimum proportion of women who choose home-use over clinic use of mifepristone.

Key facts

Study ID

NCT00994734

Run by

Gynuity Health Projects

People needed

615

Starts

2009-05-01

Expected to finish

2011-02-01

Last updated by the study team

2012-04-17

Who can join

Age: 18 and older, up to 55. Sex: female. Healthy volunteers: accepted.

You may qualify if…

• Reproductive age women seeking abortion services.
• Eligible women will be in general good health and assessed by a clinician to have an intrauterine pregnancy less than 64 days L.M.P on the day mifepristone will be taken.
• Participants must be eligible for medical abortion according to clinician and clinic standards.
• In the United States, women only 18 years and older will be eligible to participate, unless the study site obtains a waiver to include minors.

Where it is running

• Feminist Women's Health Center — Atlanta, Georgia, United States
• Institute for Family Health — New York, New York, United States
• Family Health Center, Montefiore Medical Center — The Bronx, New York, United States
• University of Pennsylvania — Philadelphia, Pennsylvania, United States
• Municipal Clinical Hospital — Chisinau, Moldova
• Kathmandu Medical College — Kathmandu, Nepal
• Nepal Medical College Teaching Hospital — Kathmandu, Nepal

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.